255 related articles for article (PubMed ID: 34749750)
1. STING protects against cardiac dysfunction and remodelling by blocking autophagy.
Xiong R; Li N; Chen L; Wang W; Wang B; Jiang W; Geng Q
Cell Commun Signal; 2021 Nov; 19(1):109. PubMed ID: 34749750
[TBL] [Abstract][Full Text] [Related]
2. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
[TBL] [Abstract][Full Text] [Related]
3. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
Zhang Y; Chen W; Wang Y
Biomed Pharmacother; 2020 May; 125():110022. PubMed ID: 32106379
[TBL] [Abstract][Full Text] [Related]
4. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
Huang J; Sun W; Huang H; Ye J; Pan W; Zhong Y; Cheng C; You X; Liu B; Xiong L; Liu S
PLoS One; 2014; 9(4):e94382. PubMed ID: 24728149
[TBL] [Abstract][Full Text] [Related]
5. STING activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-κB-mediated inflammatory response.
Wang L; Zhang S; Liu H; Gao L; He L; Chen Y; Zhang J; Yang M; He C
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166997. PubMed ID: 38142758
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
[TBL] [Abstract][Full Text] [Related]
7. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
9. Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice.
Zhong P; Zeng G; Lei C; Tian G; Ouyang S; Liu F; Peng J
Biochem Biophys Res Commun; 2021 Apr; 547():15-22. PubMed ID: 33588234
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
11. Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
Ma W; Liang F; Zhan H; Jiang X; Gao C; Zhang X; Zhang K; Sun Q; Hu H; Zhao Z
Acta Physiol (Oxf); 2020 Oct; 230(2):e13519. PubMed ID: 32480429
[TBL] [Abstract][Full Text] [Related]
12. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
[TBL] [Abstract][Full Text] [Related]
13. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
[TBL] [Abstract][Full Text] [Related]
14. Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
Li R; Wang X; Wu S; Wu Y; Chen H; Xin J; Li H; Lan J; Xue K; Li X; Zhuo C; He J; Tang CS; Jiang W
J Cell Physiol; 2019 Aug; 234(10):17578-17588. PubMed ID: 30793300
[TBL] [Abstract][Full Text] [Related]
15. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
16. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of salusins alleviates hypertrophic cardiomyopathy via attenuating oxidative stress and autophagy.
Dang JY; Zhang W; Chu Y; Chen JH; Ji ZL; Feng P
Eur J Med Res; 2024 Feb; 29(1):109. PubMed ID: 38336819
[TBL] [Abstract][Full Text] [Related]
18. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling.
Gao G; Chen W; Yan M; Liu J; Luo H; Wang C; Yang P
Int J Mol Med; 2020 Jan; 45(1):195-209. PubMed ID: 31746373
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophy-Reduced Autophagy Causes Cardiac Dysfunction by Directly Impacting Cardiomyocyte Contractility.
Ott C; Jung T; Brix S; John C; Betz IR; Foryst-Ludwig A; Deubel S; Kuebler WM; Grune T; Kintscher U; Grune J
Cells; 2021 Apr; 10(4):. PubMed ID: 33916597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
